Join NFCR and Dr. Sujuan Ba in Discussion about All Things Cancer
Each episode of All Things Cancer will spotlight the most pressing topics in oncology, from cutting-edge treatments and emerging research to personal stories of resilience and hope. More than just a podcast, it’s a platform for raising awareness, advancing cancer education, and fostering a global community of support and collaboration.
Cancer impacts everyone—whether you’re a patient, caregiver, advocate, or researcher — This podcast delivers invaluable insights from those on the frontlines of the fight against it.
Check Out Our Latest Episode:
Subscribe now to stay up to date on the latest episodes and join the conversation shaping the future of cancer research.
Hosted by NFCR CEO, Sujuan Ba, Ph.D., this compelling series will bring together the entire ecosystem of cancer research—including leading scientists, oncologists, doctors, patient advocates, caregivers, biotech innovators, and survivors—for powerful discussions on the breakthroughs shaping the future of cancer research, treatment, and care.
Latest Episodes of All Things Cancer
Episode #3
FEATURING: Dr. Dennis Slamon, UCLA Health
Dr. Dennis Slamon, recipient of the 2024 Szent-Györgyi Prize for Progress in Cancer Research, joins us on our latest episode of the All Things Cancer podcast to discuss his groundbreaking work in cancer research, particularly his role in developing the drug Herceptin (trastuzumab).
Episode #2
FEATURING: Dr. Azra Raza, Columbia University
Dr. Azra Raza is a renowned oncologist, researcher, and author of The First Cell. In this episode, Dr. Raza shares her groundbreaking research, the urgent need for a paradigm shift in cancer treatment, and how we can move toward real change.
Episode #1
FEATURING: Dr. Margaret Foti, CEO of the American Association for Cancer Research (AACR)
Dr. Maragaret Foti serves as CEO of the American Association for Cancer Research and was awarded the 2024 AIM-HI Beacon Award for Women Leaders in Oncology. In this first episode, Dr. Foti shares her extensive expertise in advancing cancer research, the challenges and opportunities in the field today, and why collaboration is crucial for accelerating progress toward cures.
